                         SEQUENCE LISTING

<110>  Albert Einstein College of Medicine
 
<120>  USE OF CHAPERONE-MEDIATED AUTOPHAGY ACTIVATORS FOR TREATING OR 
       PREVENTING BLOOD CANCERS AND MYELODYSPLASTIC SYNDROMES

<130>  EIN0009PCT

<150>  US 63/136,974
<151>  2021-01-13

<160>  16    

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Mouse FADS2 forward primer

<400>  1
gctctcagat caccgaggac                                                   20


<210>  2
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Mouse FADS reverse primer

<400>  2
agtgccgaag tacgagagga                                                   20


<210>  3
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Mouse L2A forward primer

<400>  3
gcagtgcaga tgaagacaac                                                   20


<210>  4
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Mouse L2A reverse primer

<400>  4
agtatgatgg cgcttgagac                                                   20


<210>  5
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Mouse L2B forward primer

<400>  5
ggtgctggtc tttcaggctt gatt                                              24


<210>  6
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Mouse L2B reverse primer

<400>  6
accacccaat ctaagagcag gact                                              24


<210>  7
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Mouse L2C forward primer

<400>  7
atgtgctgct gactctgacc tcaa                                              24


<210>  8
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Mouse L2C reverse primer

<400>  8
tggaagcacg agactggctt gatt                                              24


<210>  9
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Human L2A forward primer

<400>  9
tgacgacaac ttccttgtgc                                                   20


<210>  10
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Human L2A reverse primer

<400>  10
agcatgatgg tgcttgagac                                                   20


<210>  11
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Mouse beta-actin, forward primer

<400>  11
aaggactcct atagtgggtg acga                                              24


<210>  12
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Mouse beta-actin reverse primer

<400>  12
atcttctcca tgtcgtccca gttg                                              24


<210>  13
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Mouse TBP forward primer

<400>  13
gttgggcttc ccagctaagt                                                   20


<210>  14
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Mouse TBP reverse primer

<400>  14
cacaaggcct tccagcctta                                                   20


<210>  15
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  FADS2 peptide, mouse

<400>  15

Lys Val Tyr Asn Val Thr Lys 
1               5           


<210>  16
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  FADS2 peptide, mouse

<400>  16

Trp Leu Val Ile Asp Arg Lys 
1               5           


